T-cell-mediated immunity is crucial for the control of Chlamydia in mi
ce. Recent evidence from studies in an in vitro model of the mucosal e
pithelium, the polarized epithelial-lymphocyte coculture (PELC) system
, indicated that protective murine T cells mediated intracellular inhi
bition of the Chlamydia trachomatis agent of mouse pneumonitis (MoPn)
at least partly by activating the interferon-gamma (IFN-gamma)-inducib
le nitric oxide synthase (iNOS) pathway. To investigate whether nitric
oxide played a role in controlling chlamydial infection in vivo, the
protective capacity of a chlamydial-specific T-cell clone (clone 2.14-
0) was analysed in mice in the presence of a specific inhibitor of iNO
S. The results revealed that the ability of this clone to clear Chlamy
dia in vivo is in part mediated by induction of nitric oxide (NO) prod
uction. The L-arginine analogue and iNOS inhibitor, N-G-monomethyl-L-a
rginine monoacetate (MLA), increased the chlamydial burden in infected
mice and inhibited the ability of clone 2.14-0 to clear genital MoPn
infection in vivo. The results are consistent with the working hypothe
sis that the IFN-gamma-inducible iNOS pathway is involved in the contr
ol of Chlamydia by T lymphocytes in mice.